valproic acid has been researched along with substance p in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caffarri, G; Capretti, L; Cavazzini, U; Chiodera, P; Coiro, V; Davoli, C; Marcato, A; Rossi, G; Volpi, R | 1 |
| Bossut, D; Frenk, H; Mayer, DJ | 1 |
| Mantegazza, P; Martini, A; Panerai, AE; Sacerdote, P | 1 |
| Ayata, C; Cutrer, FM; Lee, WS; Limmroth, V; Moskowitz, MA; Waeber, C; Yu, X | 1 |
| Akundi, RS; Fiebich, BL; Hamke, M; Lieb, K; Treffurth, Y; von Kleinsorgen, M | 1 |
| Geyer, MA; Kuczenski, R; Lohr, JB; Niculescu, AB; Ogden, CA; Paulus, MP; Rich, ME; Schork, NJ | 1 |
1 trial(s) available for valproic acid and substance p
| Article | Year |
|---|---|
Stimulation of ACTH/cortisol by intravenously infused substance P in normal men: inhibition by sodium valproate.
Topics: Adrenocorticotropic Hormone; Adult; gamma-Aminobutyric Acid; Humans; Hydrocortisone; Infusions, Intravenous; Male; Reference Values; Sodium Chloride; Substance P; Synaptic Transmission; Valproic Acid | 1992 |
5 other study(ies) available for valproic acid and substance p
| Article | Year |
|---|---|
Is substance P a primary afferent neurotransmitter for nociceptive input? III. Valproic acid and chlordiazepoxide decrease behaviors elicited by intrathecal injection of substance P and excitatory compounds.
Topics: Animals; Anticonvulsants; Chlordiazepoxide; Injections, Spinal; Kainic Acid; Male; Morphine; Nociceptors; Pain; Rats; Rats, Inbred Strains; Spinal Cord; Strychnine; Substance P; Valproic Acid | 1988 |
Antiepileptic agents affect hypothalamic beta-endorphin concentrations.
Topics: Animals; Anticonvulsants; beta-Endorphin; Endorphins; Ethosuximide; Hypothalamus; Kinetics; Phenobarbital; Phenytoin; Rats; Rats, Inbred Strains; Somatostatin; Substance P; Valproic Acid | 1984 |
Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation.
Topics: Animals; Baclofen; Blood Pressure; Capillary Permeability; Capsaicin; Dura Mater; Electric Stimulation; Extravasation of Diagnostic and Therapeutic Materials; GABA Agents; GABA Agonists; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Heart Rate; Iodine Radioisotopes; Male; Muscimol; Neuritis; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Serum Albumin, Bovine; Substance P; Trigeminal Ganglion; Valproic Acid | 1995 |
Valproic acid inhibits substance P-induced activation of protein kinase C epsilon and expression of the substance P receptor.
Topics: Animals; Anticonvulsants; Antimanic Agents; Carbamazepine; Cells, Cultured; Drug Stability; Enzyme Activation; Humans; Interleukin-6; Lithium; Protein Kinase C; Protein Kinase C-epsilon; Rats; Rats, Wistar; Receptors, Neurokinin-1; Substance P; Valproic Acid | 2003 |
Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach.
Topics: Animals; Antimanic Agents; Bayes Theorem; Bipolar Disorder; Brain; Central Nervous System Stimulants; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Enkephalins; Gene Expression Profiling; Genetic Linkage; Genetic Predisposition to Disease; Genetic Testing; Genomics; Humans; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microarray Analysis; Nerve Tissue Proteins; Pharmacogenetics; Phosphoproteins; Protein Precursors; Substance P; Tachykinins; Valproic Acid | 2004 |